The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatitein vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Calcified Tissue Research

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF02196199PMID 5500673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates

  2005cited by this paper
• Fate of intravenously injected pyrophosphate-32P in dogs.

  1970cited by this paper
• The Inhibitory Effect of Phosphonates on the Formation of Calcium Phosphate Crystals in vitro and on Aortic and Kidney Calcification in vivo

  1970cited by this paper
• Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo

  1969cited by this paper
• Prevention by a Diphosphonate of Immobilization “Osteoporosis” in Rats

  1969cited by this paper
• Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in vitro and Pathological Calcification in vivo

  1969cited by this paper
• Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure.

  1969cited by this paper
• Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture.

  1969cited by this paper
• Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats.

  1968cited by this paper
• Isolation of inorganic pyrophosphate from bovine and human teeth.

  1968cited by this paper
• Effect of phosphate supplements in patients with fractures.

  1967cited by this paper
• Effect of Pyrophosphate on Hydroxyapatite and Its Implications in Calcium Homeostasis

  1966cited by this paper
• Effect of Pyrophosphate on Dissolution of Hydroxyapatite and Its Possible Importance in Calcium Homeostasis.∗

  1966cited by this paper
• Inorganic phosphate treatment of hypercalcemia of diverse etiologies.

  1966cited by this paper
• Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture.

  1966cited by this paper
• Inhibition of skin calcification (Calciphylaxis) by polyphosphates

  1966cited by this paper
• Effect of phosphates upon experimental skin calcinosis.

  1966cited by this paper
• Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined medium.

  1961cited by this paper
• Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase.

  1961cited by this paper
• The occurrence of pyrophosphate in bone.

  1958cited by this paper
• [Mineral constituents of calcified tissue. V. Separation and identification of pyrophosphates in osseus tissue].

  1957cited by this paper
• Synthetic High Molecular Weight Enzyme Inhibitors. I. Polymeric Phosphates of Phloretin and Related Compounds.

  1953cited by this paper

• Identification of small molecule inhibitors of Trypanosoma PEX15– PEX6 interaction

  2025cites this paper
• Advancements in Bone Replacement Techniques–Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ)

  2025cites this paper
• Strategies to reduce the onset of sleeve gastrectomy associated bone loss (STRONG BONES): Trial design and methods

  2023cites this paper
• Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women

  2023cites this paper
• Multiple Myeloma and the Role of Bisphosphonates in Its Management

  2023cites this paper
• Management of insufficiency fractures associated with long-term bisphosphonate therapy in a cat

  2023cites this paper
• Bisphosphonates as Radiopharmaceuticals: Spotlight on the Development and Clinical Use of DOTAZOL in Diagnostics and Palliative Radionuclide Therapy

  2023cites this paper
• Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study

  2022cites this paper
• Multimodal and Multiscale Characterization of the Bone‐Bacteria Interface in a Case of Medication‐Related Osteonecrosis of the Jaw

  2022cites this paper
• Bioactive Coatings With Anti-osteoclast Therapeutic Agents for Bone Implants: Enhanced Compliance and Prolonged Implant Life.

  2022cites this paper
• Fifty years of impact on treating bone disease: a commentary on Gasser et al.

  2022cites this paper
• An Impressive Approach in Nuclear Medicine: Theranostics.

  2021cites this paper
• Postoperative bisphosphonate do not significantly alter the fusion rate after lumbar spinal fusion: a meta-analysis

  2021cites this paper
• Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases

  2021cites this paper
• A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation

  2021cites this paper
• Treatment of Temporomandibular Joint Heterotopic Ossificans: A Novel Protocol With Multimodal Therapy Based on Literature Review and Presentation of a Unique Case Reportc.

  2021cites this paper
• Phosphorus-containing compounds regulate mineralization

  2021cites this paper
• Multilayer Mg-pyrophosphate glass ceramic with discontinuous bioactivity. Physicochemical characterization

  2021cites this paper
• Bisphosphonates pharmacology and use in the treatment of osteoporosis

  2021cites this paper
• Chemistry of Bisphosphonates

  2020cites this paper
• Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention

  2020cites this paper
• Surgical Strategies in Osteoporotic Bone

  2020cites this paper
• α-Heteroatom-substituted gem-Bisphosphonates: Advances in the Synthesis and Prospects for Biomedical Application

  2019cites this paper
• The Effects of Zoledronate on the Structure , Dissolution and Bioactivity of the Bioglass Composite : An Investigation by MAS-NMR and ICP-OES Methods

  2019cites this paper
• Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis

  2019cites this paper
• Clinical Pharmacology of Bisphosphonates

  2019cites this paper
• Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone

  2019cites this paper
• Isotope microscopic assessment for localization of 15N-minodeonate in bone

  2018cites this paper
• Alendronate induces osteoclast precursor apoptosis via peroxisomal dysfunction mediated ER stress

  2018cites this paper
• Mandibular Implant Prostheses

  2018cites this paper
• Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond

  2018cites this paper
• Pharmacological Risk Assessment for Dental Implants

  2018cites this paper
• Effects of the Introduction of Zoledronate on the Structure , Dissolution and Bioactivity of Bioglass Composite-MAS-NMR and ICP-OES Investigations

  2018cites this paper
• Treatment of the failed intramedullary fixation using long cephalomedullary nail for atypical subtrochanteric femoral fractures

  2018cites this paper
• A microbiological study of medication-related osteonecrosis of the jaw (MRONJ) and actinomyces involvement in the disease

  2018cites this paper
• Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair

  2018cites this paper
• Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  2018cites this paper
• New agents in the Treatment of Myeloma Bone Disease

  2017cites this paper
• Studies regarding the induced thermal degradation, kinetic analysis and possible interactions with various excipients of an osseointegration agent: zoledronic acid

  2017cites this paper
• G protein‐coupled receptors as anabolic drug targets in osteoporosis

  2017cites this paper
• Fluorous-tag assisted synthesis of bile acid-bisphosphonate conjugates via orthogonal click reactions: an access to potential anti-resorption bone drugs.

  2017cites this paper
• Targeting Trypanosoma brucei FPPs by fragment- based drug discovery

  2017cites this paper
• New bioactive glass scaffolds with exceptional qualities for bone tissue regeneration: response of osteoblasts and osteoclasts

  2017cites this paper
• Cell-bioactive glass scaffold interactions: Biological response to chemistry and topology

  2017cites this paper
• Healing of Atypical Subtrochanteric Femur Fractures After Cephalomedullary Nailing: Which Factors Predict Union?

  2017cites this paper
• Localization of Minodronate in Mouse Femora Through Isotope Microscopy

  2016cites this paper
• Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine.

  2016cites this paper
• Pyrophosphate: a key inhibitor of mineralisation.

  2016cites this paper
• An Evaluative History of Bisphosphonate Drugs: Dual Physiologic Effects of Pyrophosphate as Inspiration for a Novel Pharmaceutical Class

  2016cites this paper
• The effects of biphosphonate use in the healing of hip fractures: A systematic review

  2016cites this paper
• Ab initio Investigation of Adsorption Characteristics of Bisphosphonates on Hydroxyapatite (001) Surface

  2016cites this paper
• Bisphosphonates for Osteoporosis

  2015cites this paper
• Ab initio investigation of the adsorption of zoledronic acid molecule on hydroxyapatite (001) surface: an atomistic insight of bone protection

  2015cites this paper
• Effect of local delivery of HEBP and inorganic pyrophosphate on bone healing

  2015cites this paper
• Complexation of Sm3+ and pamidronate: A DFT study

  2015cites this paper
• How Long to Treat with Bisphosphonates

  2015cites this paper
• Recognition of the Causative Agent of “Phossy Jaw” and “Fragile Femur” in Fumes Arising from White Phosphorus

  2015cites this paper
• Bisphosphonates and their influence on fracture healing: a systematic review

  2015cites this paper
• Histological Analysis of Microbial Colonization and Osteoclastic Activity in Bisphosphonate-Treated Rats

  2015cites this paper
• SYNTHESIS OF NOVEL BIFUNCTIONAL BISPHOSPHONATES

  2014cites this paper
• Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites.

  2014cites this paper
• Modifications de la composition et de la structure moléculaire du tissu osseux sous l'influence des bisphosphonates

  2014cites this paper
• Bone safety with risedronate: histomorphometric studies at different dose levels and exposure

  2014cites this paper
• Crystalline Calcium Alendronate Obtained by Octacalcium Phosphate Digestion: A New Chance for Local Treatment of Bone Loss Diseases?

  2013cites this paper
• Bisphosphonate-related osteonecrosis of the jaw

  2013cites this paper
• Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry.

  2013cites this paper
• Bisphosphonates: Pharmacology and Use in the Treatment of Osteoporosis

  2013cites this paper
• Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

  2013cites this paper
• Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis

  2012cites this paper
• Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms.

  2012cites this paper
• The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics.

  2012cites this paper
• Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials.

  2012cites this paper
• THE INFLUENCE O F TWO DIPHOSPHONATES ON CALCIUM METABOLISM I N THE RAT

  2012cites this paper
• Studies on polymer conjugation as versatile tool for drug delivery

  2012cites this paper
• Drugs for Disorders of Bone: Pharmacological and Clinical Considerations

  2012cites this paper
• Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids.

  2012cites this paper
• Forced eruption as an alternative to tooth extraction in long-term use of oral bisphosphonates: review, risks and technique.

  2012cites this paper
• Oral health and bisphopshonate-associated jaw osteonecrosis

  2012cites this paper
• Mécanismes d'adsorption du risédronate par des phosphates de calcium biologiques: applications aux biomatériaux

  2011cites this paper
• Effect of Bisphosphonates on the Progression of Degenerative Aortic Stenosis

  2011cites this paper
• An in vitro evaluation of mesoporous titania implants

  2011cites this paper
• ALENDRONATE A PROMISING / MULTI ASPECT DRUG IN THE MANAGEMENT OF OSTOEOPOROSIS

  2011cites this paper
• 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.

  2011cites this paper
• Bisphosphonates: the first 40 years.

  2011cites this paper
• All Bisphosphonates Are (or May Not Be) the Same: Potential Reasons for Clinical Differences

  2010cites this paper
• Effect of Alendronate on Healing of Extraction Sockets and Osseointegration of Implants in the Maxilla of Rats : Histologic Analysis

  2010cites this paper
• Cytokine Requirements for the Differentiation and Expansion of IL-17A– and IL-22–Producing Human Vγ2Vδ2 T Cells

  2010cites this paper
• The role of the bone marrow microenvironment in the establishment and progression of multiple myeloma

  2010cites this paper
• New insights into the mechanisms of bisphosphonates action

  2010cites this paper
• The impact of zoledronic acid on regenerate and native bone after consolidation and removal of the external fixator: an animal model study.

  2010cites this paper
• Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.

  2010cites this paper
• Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

  2010cites this paper
• A new amido phosphonate derivative of carboxymethylcellulose with an osteogenic activity and which is capable of interacting with any Ti surface.

  2010cites this paper
• Effect of Tetracalcium Dimagnesium Phytate on Bone Characteristics in Ovariectomized Rats

  2010cites this paper
• Differences between bisphosphonates in binding affinities for hydroxyapatite.

  2010cites this paper
• Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.

  2010cites this paper
• Review of osteoporosis pharmacotherapy for geriatric patients.

  2009cites this paper
• Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.

  2009cites this paper
• Alendronate treatment does not inhibit bone formation within biphasic calcium phosphate ceramics in posterolateral spinal fusion: an experimental study in porcine model.

  2009cites this paper
• Effects of bisphosphonate on the remodeling of rat sagittal suture after rapid expansion.

  2009cites this paper